Pacemakers Market by Implantability, Technology, Type, End User - Global Forecast to 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 15, 2018--The “Pacemakers Market by Implantability, Technology, Type, End User - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering .The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2%.The pacemakers market is driven by various factors such by increasing prevalence of cardiovascular diseases and technological advancements in devices. However, the high cost of pacemakers and an unfavorable reimbursement scenario are expected to limit market growth to a certain extent.
The dual-chamber pacemakers segment is expected to grow at a higher CAGR during the forecast period.
The dual-chamber pacemakers are the faster-growing segment in the pacemakers market, by technology. The pacemakers market, by technology, has been categorized into single-chamber pacemakers, dual-chamber, and bi ventricular/CRT pacemakers. Dual-chamber pacemakers are the most popular of all pacemaker technologies in the market, due to the higher efficiency and cost-effectiveness of dual-chamber pacemakers in atrioventricular block or sick sinus syndrome.
The hospitals & cardiac centers, by end user, is projected to hold the largest market share during the forecast period.
This segment includes both government and private hospitals and cardiac centers that provide treatment to patients with cardiac diseases. A number of factors, such as the increasing prevalence of cardiovascular diseases and the subsequent increase in the number of surgical procedures performed, improving healthcare infrastructure, and favorable reimbursement scenario are driving the growth of the pacemakers market for hospitals & cardiac centers.
Asia Pacific is expected to record the highest growth rate during the forecast period.
The Asia Pacific pacemakers market, particularly in China, Japan, India, is expected to witness high growth in the next five years. This can largely be attributed to the increasing prevalence of CVDs in these countries due to various factors such as increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking.
The pacemakers market comprises major providers such Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China). The study includes an in-depth competitive analysis of these key players in the pacemakers market, along with their company profiles, recent developments, and key market strategies.
DriversIncreasing Burden of CVDTechnological Advancements
RestraintsHigh Cost of Pacemakers, Unfavorable Reimbursement Scenario
OpportunitiesEmerging MarketsImplantable Micropacemakers Designed for Fetal Use
ChallengesShortage of Cardiac SurgeonsFrequent Product Recalls
Key Topics Covered1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Pacemaker Market, By Implantability
7 Pacemaker Market, By Technology
8 Pacemaker Market, By Type
9 Pacemaker Market, By End User
10 Pacemaker Market, By Region
11 Competitive Landscape
12 Company ProfilesAbbott LaboratoriesBiotronikBoston ScientificLepu MedicalLivanovaMedico SpAMedtronicOscorOsypka MedicalShree Pacetronix
For more information about this report visit https://www.researchandmarkets.com/research/36gqkn/pacemakers_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181115005375/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Devices
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/15/2018 04:39 AM/DISC: 11/15/2018 04:38 AM